Uveitis Completed Phase 1 Trials for Daclizumab (DB00111)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00078689Daclizumab and Sirolimus to Treat UveitisTreatment
NCT00001526ANTI-TAC THERAPY FOR UVEITISTreatment